India is a huge market for the allergy/immunology business, and the industry has recorded a healthy growth rate on a year-on-year basis. The growing health consciousness among the people, coupled with more available income to spare on diagnostic services, have boosted the immunology business within the country. The Indian immunology market segment is dominated by ELISA and semi-quantitative methods. In recent years, older techniques such as radio-immunoassay (RIA) are increasingly giving way to newer technologies such as chemiluminescence immunoassay (CLIA) and immuno-fluorescence immunoassay (IFA) that are gaining prominence. A large part of immunology testing in diagnostic laboratories in India comprises testing for thyroid and infectious diseases. The rest of the market is made up of fertility testing, cardiac markers, tumor markers and esoteric testing. A growing number of diagnostic laboratories are offering newer types of immunology tests that are attracting a lot more customers than before. However, high prices and lower profitability are two factors that the industry needs to take care of for continued future growth. Hide this